NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
10.70
+4.21 (64.87%)
At close: Sep 15, 2025, 4:00 PM EDT
9.80
-0.90 (-8.41%)
After-hours: Sep 15, 2025, 7:59 PM EDT
NanoVibronix Market Cap
NanoVibronix has a market cap or net worth of $8.53 million as of September 15, 2025. Its market cap has increased by 433.38% in one year.
Market Cap
8.53M
Enterprise Value
6.58M
1-Year Change
433.38%
Ranking
Category
Stock Price
$10.70
Market Cap Chart
Since May 28, 2015, NanoVibronix's market cap has decreased from $6.43B to $8.53M, a decrease of -99.87%. That is a compound annual growth rate of -47.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 8.53M | 285.18% |
| Dec 31, 2024 | 2.21M | -5.92% |
| Dec 29, 2023 | 2.35M | -71.52% |
| Dec 30, 2022 | 8.26M | -97.82% |
| Dec 31, 2021 | 379.13M | -91.52% |
| Dec 31, 2020 | 4.47B | -76.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |